{"schema_version":"secwatch.filing_event.v1","accession":"0001575872-24-000114","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.357189+00:00","generated_at":"2026-06-06T10:14:40.000609+00:00","sec_items":["8.01","1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"60 Degrees Pharmaceuticals closes $2.4M public offering of units and pre-funded units","bullets":["Gross proceeds ~$2.4M; net proceeds ~$1.9M after underwriter discounts and expenses.","Offering included 5,260,901 units at $0.385/unit and 999,076 pre-funded units at $0.375/unit.","Each unit consists of one share of common stock and one warrant (exercise price $0.4235, 5-year term).","Underwriters partially exercised over-allotment for 818,177 warrants.","Net proceeds to fund working capital, relaunch of ARAKODA malaria prevention, and R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001575872-24-000114","json":"https://secwatch.observer/filing/0001575872-24-000114.json","markdown":"https://secwatch.observer/filing/0001575872-24-000114.md","text":"https://secwatch.observer/filing/0001575872-24-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/0001575872-24-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/sxtp-20240129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T10:14:40.000609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}